Lethal capillary leak syndrome after a single administration of interferon beta-1b.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 10408566.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Interferon beta-1b (IFNbeta-1b) is a potent immunomodulatory drug in the treatment of MS. We report a lethal capillary leak syndrome after the administration of IFNbeta-1b in a patient with disseminated white matter disease, monoclonal gammopathy, and acquired C1 inhibitor (C1-INH) deficiency. IFNbeta-1b may cause a transient release of proinflammatory cytokines finally resulting in an uninhibited activation of the complement cascade in patients with C1-INH deficiency.
Medical subject headings
- Capillary Leak Syndrome
- Interferon-beta
- Multiple Sclerosis